Tevogen Bio Holdings

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TVGN and other ETFs, options, and stocks.

About TVGN

Tevogen Bio Holdings, Inc. is a clinical-stage specialty immunotherapy company, which engages in the provision of off-the-shelf therapies for the treatment of infectious diseases, cancers, and neurological disorders. It focuses on its product, ExacTcell, a technology that treats acute viral infections, long-term consequences of viral infections, and viral and non-viral induced cancers. 

CEO
Ryan Saadi
CEORyan Saadi
Employees
18
Employees18
Headquarters
Warren, New Jersey
HeadquartersWarren, New Jersey
Founded
2021
Founded2021
Employees
18
Employees18

TVGN Key Statistics

Market cap
31.28M
Market cap31.28M
Price-Earnings ratio
-0.87
Price-Earnings ratio-0.87
Dividend yield
Dividend yield
Average volume
24.31K
Average volume24.31K
High today
$8.05
High today$8.05
Low today
$6.61
Low today$6.61
Open price
$6.84
Open price$6.84
Volume
65.55K
Volume65.55K
52 Week high
$75.50
52 Week high$75.50
52 Week low
$6.22
52 Week low$6.22

Stock Snapshot

The current Tevogen Bio Holdings(TVGN) stock price is $7.75, with a market capitalization of 31.28M. The stock trades at a price-to-earnings (P/E) ratio of -0.87.

As of 2026-03-10, Tevogen Bio Holdings(TVGN) stock has fluctuated between $6.61 and $8.05. The current price stands at $7.75, placing the stock +17.2% above today's low and -3.7% off the high.

Tevogen Bio Holdings(TVGN) shares are trading with a volume of 65.55K, against a daily average of 24.31K.

In the last year, Tevogen Bio Holdings(TVGN) shares hit a 52-week high of $75.50 and a 52-week low of $6.22.

In the last year, Tevogen Bio Holdings(TVGN) shares hit a 52-week high of $75.50 and a 52-week low of $6.22.

TVGN News

TipRanks 3d
Tevogen CEO says ‘actively evaluating potential acquisitions’

Dr. Ryan Saadi, Founder & CEO Tevogen (TVGN), sent the following letter to shareholders: “Dear Shareholders, As we continue executing on Tevogen’s long-term str...

Benzinga 3d
Tevogen Bio Explores Buyout To Boost Generics Platform

Tevogen Bio Holdings (NASDAQ:TVGN) shares are wobbling on Friday as the company is advancing its generics strategy through a signed letter of intent to evaluate...

Tevogen Bio Explores Buyout To Boost Generics Platform

People also own

Based on the portfolios of people who own TVGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.